Innate Pharma SA
IPHA2.110USD
-0.040-1.86%
收盤 08/04, 16:00（美東）報價延遲15分鐘
176.84M總市值
--本益比TTM
關於 Innate Pharma SA 公司
Innate Pharma SA 是一家總部位於法國的生物製藥公司，開發用於治療癌症和炎症疾病的藥物。該公司識別和描述候選藥物、選擇適應症並管理產品的臨牀前和臨牀開發。Innate Pharma 主要專注於開發用於治療癌症以及治療傳染病和慢性炎症病理的新型治療方案和單克隆抗體。該公司開發兩類免疫療法：免疫調節劑和細胞毒性抗體。該公司與百時美施貴寶合作開展 I 期癌症抗體計劃，與 Novo Nordisk A/S 合作開展兩項炎症治療抗體計劃。該公司通過抗 NKG2A 抗體開展業務，這是 Novo Nordisk 準備用於腫瘤學 II 期開發的免疫檢查點抑制劑。它還與阿斯利康建立了多產品合作伙伴關係。
公司簡介
公司代碼IPHA
公司名稱Innate Pharma SA
上市日期Oct 31, 2006
CEOMr. Jonathan Elliot Dickinson
員工數量- -
證券類型Depository Receipt
年結日Oct 31
公司地址117 avenue de Luminy
城市MARSEILLE
上市交易所NASDAQ Global Select Consolidated
國家France
郵編13009
電話33430303030
網址https://www.innate-pharma.com/
公司代碼IPHA
上市日期Oct 31, 2006
CEOMr. Jonathan Elliot Dickinson
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Prof. Eric Vivier, Ph.D.
Prof. Eric Vivier, Ph.D.
Senior Vice President, Chief Scientific Officer, Member of the Leadership Team
Senior Vice President, Chief Scientific Officer, Member of the Leadership Team
--
--
Mr. Nicola Beltraminelli
Mr. Nicola Beltraminelli
Vice President, Chief Development Officer, Member of the Leadership Team
Vice President, Chief Development Officer, Member of the Leadership Team
--
--
Mr. Frederic Lombard
Mr. Frederic Lombard
Chief Financial Officer, Member of the Leadership Team
Chief Financial Officer, Member of the Leadership Team
--
--
Mr. Gilles Brisson
Mr. Gilles Brisson
Member of the Supervisory Board
Member of the Supervisory Board
--
--
Mr. Henry Wheeler
Mr. Henry Wheeler
Vice President - Investor Relations and Communications, Member of the Leadership Team
Vice President - Investor Relations and Communications, Member of the Leadership Team
--
--
Ms. Odile Belzunce
Ms. Odile Belzunce
Vice President - Compliance, IT and Portfolio Management, Member of the Leadership Team
Vice President - Compliance, IT and Portfolio Management, Member of the Leadership Team
--
--
Mr. Olivier Martinez
Mr. Olivier Martinez
Member of the Supervisory Board, Representative of Bpifrance Participations
Member of the Supervisory Board, Representative of Bpifrance Participations
--
--
Ms. Claire De Saint-blanquat
Ms. Claire De Saint-blanquat
Vice President - Legal and Corporate Affairs, Secretary of the Supervisory Board, Member of the Leadership Team
Vice President - Legal and Corporate Affairs, Secretary of the Supervisory Board, Member of the Leadership Team
--
--
Dr. Sally Bennett
Dr. Sally Bennett
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Ms. Veronique Chabernaud, M.D.
Ms. Veronique Chabernaud, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Prof. Eric Vivier, Ph.D.
Prof. Eric Vivier, Ph.D.
Senior Vice President, Chief Scientific Officer, Member of the Leadership Team
Senior Vice President, Chief Scientific Officer, Member of the Leadership Team
--
--
Mr. Nicola Beltraminelli
Mr. Nicola Beltraminelli
Vice President, Chief Development Officer, Member of the Leadership Team
Vice President, Chief Development Officer, Member of the Leadership Team
--
--
Mr. Frederic Lombard
Mr. Frederic Lombard
Chief Financial Officer, Member of the Leadership Team
Chief Financial Officer, Member of the Leadership Team
--
--
Mr. Gilles Brisson
Mr. Gilles Brisson
Member of the Supervisory Board
Member of the Supervisory Board
--
--
Mr. Henry Wheeler
Mr. Henry Wheeler
Vice President - Investor Relations and Communications, Member of the Leadership Team
Vice President - Investor Relations and Communications, Member of the Leadership Team
--
--
Ms. Odile Belzunce
Ms. Odile Belzunce
Vice President - Compliance, IT and Portfolio Management, Member of the Leadership Team
Vice President - Compliance, IT and Portfolio Management, Member of the Leadership Team
--
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 5月16日 週五
更新時間: 5月16日 週五
持股股東
股東類型
持股股東
持股股東
佔比
AllianceBernstein L.P.
0.07%
Morgan Stanley & Co. International Plc
0.05%
Citadel Advisors LLC
0.03%
Millennium Management LLC
0.02%
Other
99.84%
持股股東
持股股東
佔比
AllianceBernstein L.P.
0.07%
Morgan Stanley & Co. International Plc
0.05%
Citadel Advisors LLC
0.03%
Millennium Management LLC
0.02%
Other
99.84%
股東類型
持股股東
佔比
Investment Advisor/Hedge Fund
0.07%
Research Firm
0.05%
Hedge Fund
0.04%
Investment Advisor
0.01%
Other
99.83%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
17
157.41K
0.17%
-54.22K
2025Q1
22
261.37K
0.29%
-22.81K
2024Q4
23
278.64K
0.34%
-188.16K
2024Q3
25
406.53K
0.50%
-579.77K
2024Q2
27
405.72K
0.50%
-529.94K
2024Q1
29
344.92K
0.22%
-517.69K
2023Q4
32
202.70K
0.25%
-1.13M
2023Q3
36
377.53K
0.47%
-1.02M
2023Q2
36
293.58K
0.36%
-1.21M
2023Q1
33
404.31K
0.50%
-1.20M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
AllianceBernstein L.P.
60.75K
0.07%
+36.48K
+150.33%
Jun 30, 2024
Morgan Stanley & Co. International Plc
43.52K
0.05%
--
--
Mar 31, 2025
Citadel Advisors LLC
24.27K
0.03%
+12.41K
+104.73%
Mar 31, 2025
Millennium Management LLC
15.33K
0.02%
+15.33K
--
Mar 31, 2025
UBS Financial Services, Inc.
9.00K
0.01%
+5.49K
+156.44%
Mar 31, 2025
GAMMA Investing LLC
2.23K
0%
+2.23K
--
Mar 31, 2025
Rhumbline Advisers Ltd. Partnership
675.00
0%
--
--
Mar 31, 2025
Barclays Bank PLC
307.00
0%
--
--
Mar 31, 2025
Optiver Holding B.V.
101.00
0%
--
--
Mar 31, 2025
Tower Research Capital LLC
3.00
0%
+3.00
--
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
ActivePassive International Equity ETF
0%
DFA Dimensional Intl Sustainability Core 1 ETF
0%
DFA Dimensional International Core Equity 2 ETF
0%
ActivePassive International Equity ETF
佔比0%
DFA Dimensional Intl Sustainability Core 1 ETF
佔比0%
DFA Dimensional International Core Equity 2 ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
